Works matching IS 00192805 AND DT 2022 AND VI 166 AND IP 3
Results: 13
Editorial: Streamlining the process of submissions to Immunology.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 267, doi. 10.1111/imm.13521
- Publication type:
- Article
Featured Cover.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. i, doi. 10.1111/imm.13514
- Publication type:
- Article
ERRATUM.
- Published in:
- 2022
- Publication type:
- Correction Notice
cGAS modulates cytokine secretion and bacterial burdens by altering the release of mitochondrial DNA in pseudomonas pulmonary infection.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 408, doi. 10.1111/imm.13482
- By:
- Publication type:
- Article
Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 380, doi. 10.1111/imm.13481
- By:
- Publication type:
- Article
A cross‐kingdom view on the immunomodulatory role of MIF/D‐DT proteins in mammalian and plant Pseudomonas infections.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 287, doi. 10.1111/imm.13480
- By:
- Publication type:
- Article
Retinal microglia: Functions and diseases.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 268, doi. 10.1111/imm.13479
- By:
- Publication type:
- Article
T cell‐intrinsic miR‐155 is required for Th2 and Th17‐biased responses in acute and chronic airway inflammation by targeting several different transcription factors.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 357, doi. 10.1111/imm.13477
- By:
- Publication type:
- Article
Activation of T cell checkpoint pathways during β‐cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 341, doi. 10.1111/imm.13476
- By:
- Publication type:
- Article
Adoptive transfer of IL‐4 reprogrammed Tc17 cells elicits anti‐tumour immunity through functional plasticity.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 310, doi. 10.1111/imm.13473
- By:
- Publication type:
- Article
The effect of age on the magnitude and longevity of Th1‐directed CD4 T‐cell responses to SARS‐CoV‐2.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 327, doi. 10.1111/imm.13475
- By:
- Publication type:
- Article
1,25‐Dihydroxyvitamin D3 suppresses CD4<sup>+</sup> T‐cell effector functionality by inhibition of glycolysis.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. 299, doi. 10.1111/imm.13472
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Immunology, 2022, v. 166, n. 3, p. ii, doi. 10.1111/imm.13358
- Publication type:
- Article